<DOC>
	<DOC>NCT01357460</DOC>
	<brief_summary>Patients with advanced heterogeneous emphysema due to alpha1 antitrypsin deficiency might benefit from endoscopic implantation of intrabronchial valves.</brief_summary>
	<brief_title>Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency</brief_title>
	<detailed_description>Patient enrollment and data acquisition is to be carried out on a prospective basis. It is planned to enroll a total of 25 patients with advanced heterogeneous emphysema due to alpha1 antitrypsin deficiency. All patients will undergo treatment at one study centre in Heidelberg. Therapy of all patients consists of implantation of intrabronchial valves (IBV, Spiration, Olympus) in the most emphysematous destroyed lobe.</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>pulmonary function: FEV1 &lt; 45 %, RV &gt; 150 %, TLC &gt; 100 % alpha1 antitrypsin deficiency (&lt; 80 mg/dl), genotype: PiZS, PiZZ, Pi0/0 heterogenous emphysema homogenous emphysema significant bronchiectasis severe concomitant diseases pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Emphysema</keyword>
	<keyword>alpha1 antitrypsin deficiency</keyword>
	<keyword>endoscopic lung volume reduction</keyword>
</DOC>